Categories
CESPE Conference 2022 News Program

Conference program

On this page you will find all the updates considering the program of our CESPE conference on Manufacturing Innovations for a Sustainable (Bio)Pharmaceutical Industry. At this event, there will be a mix of senior industry leaders, policy makers, academics and startups. There will be a variety of talks on chemical drug substance, drug product and biotech manufacturing, providing insights in both industrial and academic state-of-the-art. There will also be ample opportunities to network with all participants. 

What’s in it for you?
You will:

  • Have access to state-of-the-art science in the field of chemical drug substance, drug product and biotech manufacturing
  • Get to know groundbreaking and disruptive manufacturing technologies
  • Expand your professional network 
  • Learn more about our new facilities planned at Tech Lane Ghent Science Park, including cleanrooms to handle potent APIs 
  • Have the latest insights in the new Master in Pharmaceutical Engineering, unique in Flanders and launched in September ’22. 
  • Have discussion opportunities with talented PhD and postdoctoral researchers through interactive poster sessions
  • Learn about access to young talent through various master thesis opportunities

High level program

  • Morning session
    • Conference opening 
    • General keynote on current trends in healthcare and the (bio)pharmaceutical landscape – Dr. Ann Van Gysel
    • Chemical drug substance manufacturing: keynote + industrial use cases + academic talks 
  • Lunch:
    • Exhibition booths + poster session 
  • Afternoon session 
    • Biotech manufacturing: keynote + industrial use cases + academic talks 
    • Drug product manufacturing: keynote + industrial use cases + academic talks 
    • Pecha Kucha session 
    • Panel discussion
  • Conference dinner + networking
Categories
CESPE Conference 2022 News Program

Keynote speaker: Dr. Ann Van Gysel

We are excited to announce Dr. Ann Van Gysel as keynote speaker at our CESPE Conference on Manufacturing Innovations for a Sustainable (Bio)Pharmaceutical Industry on September 15th in Ghent! Dr. Van Gysel was recently appointed as CEO of the spearhead cluster MEDVIA. In her keynote, she will focus on the current trends in healthcare and the (bio)pharmaceutical landscape.

Ann Van Gysel has always been passionate about innovation in healthcare. She started out as a biologist and received her PhD in molecular biology from the University of Gent. She acquired post-graduate degrees in Business Management and Marketing and Communications. In 2009, she joined FlandersBio as Managing Director. During her three-year tenure, she doubled the number of members, putting Flanders on the international map as a one of the major biotech hubs. In 2011, Ann founded Turnstone Communications, a consultancy agency providing communications and marketing services to healthcare, life sciences and pharmaceutical organizations in Belgium and abroad. She was the founder of the digital life sciences news platform BioVox.eu, sharing Belgian innovations with national and international professionals. Since January 2022 she has been the CEO of MEDVIA, a public-private partnership founded by the Flemish Government to support innovation in healthcare focusing on biotech, medtech and digital health.